UroGen Pharma Ltd.

MEITAV INVESTMENT HOUSE LTD URGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

35,517

Value ($000)

832

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	832	0.0%	35,517	12/31/2025
2025 Q3	10/29/2025	629	0.0%	31,513	9/30/2025
2025 Q2	7/23/2025	495	0.0%	36,138	6/30/2025
2025 Q1	5/12/2025	400	0.0%	36,138	3/31/2025
2024 Q4	2/3/2025	385	0.0%	36,138	12/31/2024
2024 Q3	10/28/2024	459	0.0%	36,138	9/30/2024
2024 Q2	7/29/2024	617	0.0%	36,798	6/30/2024
2024 Q1	5/1/2024	552	0.0%	36,798	3/31/2024
2023 Q4	1/29/2024	1,372	0.0%	91,456	12/31/2023
2023 Q3	10/30/2023	1,295	0.0%	91,456	9/30/2023
2023 Q2	7/24/2023	1,105	0.0%	105,512	6/30/2023
2023 Q1	5/11/2023	1,251	0.0%	107,212	3/31/2023
2022 Q4	2/6/2023	1,184	0.0%	136,835	12/31/2022
2022 Q3	10/31/2022	1,133	0.0%	136,835	9/30/2022
2022 Q2	8/1/2022	1,121	0.0%	136,835	6/30/2022
2022 Q1	5/9/2022	1,192	0.0%	136,835	3/31/2022
2021 Q4	2/8/2022	1,495	0.0%	156,186	12/31/2021
2021 Q3	11/3/2021	2,129	0.0%	126,590	9/30/2021
2021 Q2	8/5/2021	1,535	0.0%	100,519	6/30/2021
2021 Q1	5/6/2021	1,233	0.0%	63,280	3/31/2021
2020 Q3	11/5/2020	934	0.0%	48,407	9/30/2020
2020 Q2	8/10/2020	1,128	0.1%	43,255	6/30/2020
2020 Q1	5/11/2020	544	0.0%	30,406	3/31/2020
2019 Q4	2/10/2020	9,080	0.7%	272,063	12/31/2019